Fundz

Vedana raises $46m in Series A funding to advance its migraine therapies, led by a team of biotech experts.

PRIVATEJun 17, 2026

Amount Raised

$46 Million

Round Type

Series A

IndiaBiotechnologyHealth CareTherapeutics

Investors

Alexandria Venture InvestmentsDawn BiopharmaCanaan Partners

Description

Vedana has secured $46m in Series A funding to enhance its portfolio of migraine therapies. The newly raised capital will facilitate the development of subcutaneously delivered antibodies targeting validated pathways for prevention. The expert team behind Vedana includes leaders in the development of approved migraine treatments. This funding aims to bridge the treatment gap faced by migraine patients.

Quick answer

Vedana raised $46 Million in a Series A round, dated June 17, 2026. Investors: Alexandria Venture Investments, Dawn Biopharma and Canaan Partners. Vedana is based in India.

How much did Vedana raise?
Vedana raised $46 Million in a Series A round on June 17, 2026.
Who invested in Vedana?
Alexandria Venture Investments, Dawn Biopharma and Canaan Partners are named as investors in this round.
What does Vedana do?
Vedana is a biotech startup focused on developing antibody therapies for migraine treatment.
Where is Vedana based and how big is it?
Vedana is based in India. Fundz records about 51 employees.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Vedana that raised within 45 days of this round, from Fundz verified event records.

  • Ratio Therapeutics raised $70M (Series C) on July 31, 2026.
  • Hyku Biosciences raised $8.6M on July 30, 2026.
  • HCW Biologics raised $1.5M (Post-IPO Equity) on July 29, 2026.
  • Adjuvia Therapeutics raised $8M (Seed) on July 29, 2026.
  • CORE Biomedicine raised $21M (Series A) on July 28, 2026.
  • Torrey Pines Medicine raised an undisclosed amount (Angel) on July 28, 2026.

Who to call at Vedana, and when

A new round usually means Vedana is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vedana raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vedana, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vedana. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vedana

Location

India

About

Vedana is a biotech startup focused on developing antibody therapies for migraine treatment. The company is led by experts with a history of successfully bringing migraine therapies to market, including CGRP antibodies. Vedana aims to create a best-in-class portfolio of drugs to provide migraine patients with effective treatment options. Their innovative approach includes targeting both PACAP and CGRP pathways to improve patient outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vedana raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vedana's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Vedana raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.